Business Insurance PAVmed Reports Q4 and Full Year 2024 Financial Results, Highlighting Growth and Strategic ProgressBy insurancejournalnewsMarch 25, 20250 PAVmed (NASDAQ: PAVM) announced its Q4 and full-year 2024 financial results, showcasing substantial advancements across its subsidiaries, particularly Lucid Diagnostics and Veris Health.
